Trial Profile

Prevention of Restenosis After Genous Stent Implantation Using a Paclitaxel Eluting Balloon in Coronary Arteries - a Randomized Clinical Trial.

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 17 Jul 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anti-CD34 monoclonal antibody (Primary) ; Paclitaxel
Indications Coronary artery disease; Coronary artery restenosis
Focus Therapeutic Use
Acronyms PERfECT-STENT

Most Recent Events

09 Jun 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
27 Mar 2012 Results presented at the 61st Annual Scientific Session of the American College of Cardiology.
26 May 2011 Results published in Heart.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com